$175 Million is the total value of PURA VIDA INVESTMENTS, LLC's 66 reported holdings in Q3 2015. The portfolio turnover from Q2 2015 to Q3 2015 was 52.9% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
CI | Sell | CIGNA CORPORATION | $8,236,000 | -12.0% | 61,000 | -6.2% | 4.70% | -1.9% |
UHS | Buy | UNIVERSAL HLTH SVCS INCcl b | $8,088,000 | -7.2% | 64,800 | +8.0% | 4.62% | +3.5% |
TFX | Buy | TELEFLEX INC | $7,142,000 | +9.2% | 57,500 | +17.8% | 4.08% | +21.8% |
SYK | Buy | STRYKER CORP | $7,058,000 | +38.0% | 75,000 | +50.0% | 4.03% | +53.9% |
BSX | Buy | BOSTON SCIENTIFIC CORP | $6,810,000 | +67.1% | 415,000 | +76.6% | 3.89% | +86.3% |
TFX | TELEFLEX INCcall | $6,211,000 | -8.3% | 50,000 | 0.0% | 3.54% | +2.3% | |
PFE | Buy | PFIZER INC | $6,121,000 | +19.1% | 194,875 | +36.8% | 3.49% | +32.8% |
SNN | New | SMITH & NEPHEW PLCcall | $5,250,000 | – | 150,000 | +100.0% | 3.00% | – |
NXTM | Buy | NXSTAGE MEDICAL INC | $4,889,000 | +31.6% | 310,000 | +19.1% | 2.79% | +46.7% |
PODD | Buy | INSULET CORP | $4,679,000 | +38.1% | 180,600 | +80.6% | 2.67% | +54.0% |
JNJ | New | JOHNSON & JOHNSONput | $4,668,000 | – | 50,000 | +100.0% | 2.66% | – |
T107PS | Buy | WRIGHT MEDICAL GROUP INC | $4,416,000 | +42.3% | 210,101 | +74.9% | 2.52% | +58.7% |
VRX | Buy | VALEANT PHARMACEUTICALS INTL | $4,125,000 | +28.1% | 23,125 | +85.0% | 2.35% | +42.9% |
ABBV | Buy | ABBVIE INC | $4,026,000 | +0.2% | 74,000 | +29.0% | 2.30% | +11.8% |
HOLX | New | HOLOGIC INCcall | $3,913,000 | – | 100,000 | +100.0% | 2.23% | – |
LLY | Buy | LILLY ELI & CO | $3,703,000 | +65.3% | 44,250 | +67.0% | 2.11% | +84.4% |
CYBX | CYBERONICS INC | $3,647,000 | -1.0% | 60,000 | 0.0% | 2.08% | +10.4% | |
ARAY | Buy | ACCURAY INC | $3,565,000 | +47.1% | 713,700 | +87.8% | 2.04% | +64.0% |
NUVA | Sell | NUVASIVE INC | $3,509,000 | -32.2% | 72,780 | -22.7% | 2.00% | -24.4% |
SPNC | Buy | SPECTRANETICS CORPcall | $3,419,000 | +98.1% | 290,000 | +286.7% | 1.95% | +121.0% |
ABT | New | ABBOTT LABS | $3,218,000 | – | 80,000 | +100.0% | 1.84% | – |
BMY | Buy | BRISTOL MYERS SQUIBB CO | $3,182,000 | -4.2% | 53,750 | +6.2% | 1.82% | +6.8% |
CYNA | CYNAPSUS THERAPEUTICS INC | $3,102,000 | -1.4% | 194,461 | 0.0% | 1.77% | +9.9% | |
VAR | New | VARIAN MED SYS INC | $2,951,000 | – | 40,000 | +100.0% | 1.68% | – |
VNDA | Sell | VANDA PHARMACEUTICALS INC | $2,792,000 | -25.8% | 247,500 | -19.5% | 1.59% | -17.3% |
ALIM | New | ALIMERA SCIENCES INCcall | $2,763,000 | – | 1,250,000 | +100.0% | 1.58% | – |
PRGO | Buy | PERRIGO CO PLC | $2,752,000 | -16.4% | 17,500 | +2.2% | 1.57% | -6.7% |
KITE | Buy | KITE PHARMA INC | $2,714,000 | +3.6% | 48,750 | +35.4% | 1.55% | +15.5% |
WMGIZ | Buy | WRIGHT MEDICAL GROUP RIGHTSright 03/01/2019 | $2,648,000 | +21.9% | 585,836 | +0.1% | 1.51% | +35.9% |
BXLT | New | BAXALTA INC | $2,521,000 | – | 80,000 | +100.0% | 1.44% | – |
ELGX | New | ENDOLOGIX INC | $2,515,000 | – | 205,100 | +100.0% | 1.44% | – |
EW | Sell | EDWARDS LIFESCIENCES CORP | $2,488,000 | -34.6% | 17,500 | -30.0% | 1.42% | -27.1% |
JAZZ | JAZZ PHARMACEUTICALS PLC | $2,391,000 | -30.9% | 18,000 | 0.0% | 1.36% | -22.9% | |
AFFX | Sell | AFFYMETRIX INC | $2,391,000 | -27.3% | 280,000 | -6.7% | 1.36% | -18.9% |
OMI | Sell | OWENS & MINOR INC NEW | $2,236,000 | -39.4% | 70,000 | -33.3% | 1.28% | -32.5% |
QGEN | Sell | QIAGEN NV | $2,193,000 | -21.6% | 85,000 | -15.0% | 1.25% | -12.6% |
SGYPQ | Buy | SYNERGY PHARMACEUTICALS DEL | $2,120,000 | -5.6% | 400,000 | +62.4% | 1.21% | +5.3% |
ALXN | ALEXION PHARMACEUTICALS INC | $1,955,000 | -20.8% | 12,500 | 0.0% | 1.12% | -11.6% | |
SNN | Sell | SMITH & NEPHEW PLCspdn adr new | $1,925,000 | -50.5% | 55,000 | -47.6% | 1.10% | -44.7% |
AGN | New | ALLERGAN PLC | $1,903,000 | – | 7,000 | +100.0% | 1.09% | – |
BCR | New | BARD C R INC | $1,863,000 | – | 10,000 | +100.0% | 1.06% | – |
TRXC | Buy | TRANSENTERIX INC | $1,832,000 | -26.5% | 810,404 | +6.4% | 1.05% | -18.0% |
EWA | New | ISHARESput | $1,792,000 | – | 100,000 | +100.0% | 1.02% | – |
ALQA | Buy | ALLIQUA BIOMEDICAL INC | $1,658,000 | -20.7% | 523,000 | +24.5% | 0.95% | -11.7% |
ZLTQ | New | ZELTIQ AESTHETICS INC | $1,602,000 | – | 50,000 | +100.0% | 0.91% | – |
AKRXQ | Buy | AKORN INC | $1,431,000 | -33.8% | 50,200 | +7.1% | 0.82% | -26.1% |
SAGE | SAGE THERAPEUTICS INC | $1,185,000 | -38.1% | 28,000 | 0.0% | 0.68% | -31.0% | |
TNXP | Buy | TONIX PHARMACEUTICALS HLDG C | $1,100,000 | -17.4% | 207,900 | +31.7% | 0.63% | -7.8% |
PEN | New | PENUMBRA INC | $1,035,000 | – | 25,800 | +100.0% | 0.59% | – |
FLKS | New | FLEX PHARMA INC | $865,000 | – | 72,000 | +100.0% | 0.49% | – |
ZGNX | Buy | ZOGENIX INC | $793,000 | -18.9% | 58,750 | +16.0% | 0.45% | -9.6% |
BDSI | New | BIODELIVERY SCIENCES INTL IN | $751,000 | – | 135,000 | +100.0% | 0.43% | – |
FOMX | New | FOAMIX PHAMACEUTICALS LTD | $748,000 | – | 102,000 | +100.0% | 0.43% | – |
FEIC | Sell | FEI CO | $730,000 | -43.4% | 10,000 | -33.3% | 0.42% | -36.8% |
DYAX | Buy | DYAX CORP | $449,000 | -19.0% | 23,500 | +4.4% | 0.26% | -9.9% |
OCRX | Buy | OCERA THERAPEUTICS INC | $414,000 | -10.0% | 131,000 | +11.6% | 0.24% | +0.4% |
PTCT | PTC THERAPEUTICS INCcall | $401,000 | -44.5% | 15,000 | 0.0% | 0.23% | -38.1% | |
CBAY | CYMABAY THERAPEUTICS INC | $388,000 | -35.5% | 200,000 | 0.0% | 0.22% | -28.2% | |
ALDX | ALDEYRA THERAPEUTICS INC | $335,000 | -34.4% | 57,500 | 0.0% | 0.19% | -27.1% | |
ADMP | ADAMIS PHARMACEUTICALS CORP | $312,000 | -7.4% | 80,500 | 0.0% | 0.18% | +3.5% | |
CPRX | Sell | CATALYST PHARM PARTNES INC | $300,000 | -84.6% | 100,129 | -74.7% | 0.17% | -82.9% |
CBYL | Buy | CARBYLAN THERAPEUTICS INC | $286,000 | +3.6% | 80,000 | +100.0% | 0.16% | +15.6% |
ITEK | New | INOTEK PHARMACEUTICALS CORP | $252,000 | – | 26,800 | +100.0% | 0.14% | – |
EVAR | LOMBARD MED INC | $189,000 | -12.5% | 52,875 | 0.0% | 0.11% | -2.7% | |
SRPT | SAREPTA THERAPEUTICS INCcall | $173,000 | +5.5% | 5,400 | 0.0% | 0.10% | +17.9% | |
ALIM | Sell | ALIMERA SCIENCES INC | $100,000 | -98.3% | 45,207 | -96.4% | 0.06% | -98.1% |
STAA | Exit | STAAR SURGICAL CO | $0 | – | -17,204 | -100.0% | -0.08% | – |
ARAY | Exit | ACCURAY INCcall | $0 | – | -50,000 | -100.0% | -0.16% | – |
Exit | NEURODERM LTD | $0 | – | -53,000 | -100.0% | -0.52% | – | |
IPXL | Exit | IMPAX LABORATORIES INC | $0 | – | -21,543 | -100.0% | -0.53% | – |
IRWD | Exit | IRONWOOD PHARMACEUTICALS INC | $0 | – | -100,000 | -100.0% | -0.54% | – |
NXTM | Exit | NXSTAGE MEDICAL INCcall | $0 | – | -100,000 | -100.0% | -0.73% | – |
ESPR | Exit | ESPERION THERAPEUTICS INC NEput | $0 | – | -34,500 | -100.0% | -1.10% | – |
THOR | Exit | THORATEC CORPput | $0 | – | -50,000 | -100.0% | -1.14% | – |
AGN | Exit | ALLERGAN INC | $0 | – | -7,000 | -100.0% | -1.19% | – |
RCPT | Exit | RECEPTOS INC | $0 | – | -11,000 | -100.0% | -1.28% | – |
FEIC | Exit | FEI COcall | $0 | – | -30,000 | -100.0% | -1.32% | – |
PTCT | Exit | PTC THERAPEUTICS INCput | $0 | – | -60,000 | -100.0% | -1.48% | – |
BIIB | Exit | BIOGEN INC | $0 | – | -9,250 | -100.0% | -1.51% | – |
CPHD | Exit | CEPHEID | $0 | – | -60,000 | -100.0% | -1.71% | – |
A | Exit | AGILENT TECHNOLOGIES INCcall | $0 | – | -100,000 | -100.0% | -1.97% | – |
SPNC | Exit | SPECTRANETICS CORP | $0 | – | -250,000 | -100.0% | -2.19% | – |
COO | Exit | COOPER COS INC | $0 | – | -25,000 | -100.0% | -2.26% | – |
TMO | Exit | THERMO FISHER SCIENTIFIC INCcall | $0 | – | -37,500 | -100.0% | -2.49% | – |
SIEN | Exit | SIENTRA INC | $0 | – | -241,402 | -100.0% | -2.87% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2015-11-16
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
ICU MED INC | 26 | Q2 2023 | 4.2% |
NANOSTRING TECHNOLOGIES INC | 26 | Q2 2023 | 3.3% |
VIEWRAY INC | 25 | Q2 2023 | 3.2% |
LIVANOVA PLC | 23 | Q3 2023 | 3.8% |
ALEXION PHARMACEUTICALS INC | 23 | Q1 2021 | 4.3% |
INSPIRE MED SYS INC | 22 | Q3 2023 | 3.7% |
BOSTON SCIENTIFIC CORP | 22 | Q3 2022 | 4.8% |
INVACARE CORP | 22 | Q3 2021 | 2.8% |
ESTABLISHMENT LABS HLDGS INC | 21 | Q3 2023 | 5.0% |
INTERSECT ENT INC | 21 | Q2 2021 | 2.6% |
View PURA VIDA INVESTMENTS, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
Filed | Shares | Percentage | |
---|---|---|---|
Stryve Foods Holdings, LLC | April 19, 2023 | 1,470,649 | 5.6% |
ICAD INC | March 15, 2023 | 1,277,214 | 5.0% |
ESTABLISHMENT LABS HOLDINGS INC. | February 14, 2023 | 1,002,767 | 4.1% |
Pulmonx Corp | February 14, 2023 | 1,216,258 | 3.2% |
Quotient LtdSold out | February 14, 2023 | 0 | 0.0% |
Universe Pharmaceuticals INCSold out | February 14, 2023 | 0 | 0.0% |
MedMen Enterprises, Inc. | April 29, 2022 | 139,755,072 | 21.4% |
INVACARE CORPSold out | February 14, 2022 | 0 | 0.0% |
MedAvail Holdings, Inc. | February 14, 2022 | 714,120 | 2.2% |
TELA Bio, Inc. | February 14, 2022 | 564,120 | 3.9% |
View PURA VIDA INVESTMENTS, LLC's complete significant-ownership history.
Latest filings
Type | Filed |
---|---|
SC 13G/A | 2024-02-14 |
SC 13G/A | 2024-02-14 |
SC 13G/A | 2024-02-14 |
SC 13G/A | 2024-02-14 |
SC 13G/A | 2024-02-14 |
SC 13G/A | 2024-02-14 |
SC 13G/A | 2024-02-14 |
SC 13G/A | 2024-02-14 |
13F-HR | 2024-02-13 |
SC 13D/A | 2023-12-29 |
View PURA VIDA INVESTMENTS, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.